Stock Alert: Fluidigm Soars 35% After Its COVID Saliva Test Gets FDA Emergency Use Authorization

Stock Alert: Fluidigm Soars 35% After Its COVID Saliva Test Gets FDA Emergency Use Authorization

RTTNews

Published

Shares of Fluidigm Corp. (FLDM) surged over 35% on Wednesday morning after the company said the U.S. Food and Drug Administration granted emergency use authorization for its saliva-based COVID-19 test.

Full Article